微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 31.61% | -19.93% | -9.45% | 111/157 | 50.55% | 泽璟制药 | 94.64% | 行业排名> |
| 2025-12-31 | 34.91% | -13.91% | -2.64% | 104/157 | 50.61% | 海创药业 | 99.82% | 行业排名> |
| 2025-09-30 | 35.86% | -12.57% | -6.23% | 101/157 | -2.2% | 海创药业 | 98.62% | 行业排名> |
| 2025-06-30 | 38.24% | -11.52% | -3.15% | 95/157 | 14.83% | 海创药业 | 99.57% | 行业排名> |
| 2025-03-31 | 39.48% | -9.37% | -2.64% | 94/157 | 31.96% | 海创药业 | 99.52% | 行业排名> |
| 2024-12-31 | 40.55% | 1.79% | -1.12% | 100/157 | 51.88% | 艾力斯 | 96.74% | 行业排名> |
| 2024-09-30 | 41.01% | 0.69% | -5.11% | 96/157 | 22.51% | 首药控股 | 98.96% | 行业排名> |
| 2024-06-30 | 43.22% | 6.59% | -0.79% | 91/157 | 33.12% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-03-31 | 43.56% | 13.56% | 9.35% | 89/157 | 51.76% | 百利天恒 | 97.99% | 行业排名> |
| 2023-12-31 | 39.84% | 11.89% | -2.2% | 104/157 | 51.61% | 百利天恒 | 98.92% | 行业排名> |
| 2023-09-30 | 40.73% | 16.9% | 0.46% | 102/157 | 32.47% | 迈威生物 | 98.93% | 行业排名> |
| 2023-06-30 | 40.55% | 16.17% | 5.7% | 102/157 | 38.42% | 迈威生物 | 99.59% | 行业排名> |
| 2023-03-31 | 38.36% | 2% | 7.74% | 103/157 | 52.97% | 迈威生物 | 99.8% | 行业排名> |
| 2022-12-31 | 35.6% | -11.2% | 2.18% | 111/157 | 53.83% | 迈威生物 | 99.46% | 行业排名> |
| 2022-09-30 | 34.84% | 2% | -0.18% | 105/157 | 5.64% | 迈威生物 | 99.75% | 行业排名> |
| 2022-06-30 | 34.9% | -18.3% | -12.95% | 109/157 | 20.99% | 迈威生物 | 99.67% | 行业排名> |
| 2021-12-31 | 40.09% | -11.76% | -6.15% | 103/157 | 55.2% | 迈威生物 | 99.44% | 行业排名> |
| 2021-06-30 | 42.72% | 2% | -5.98% | 91/157 | 47.23% | 迈威生物 | 98.57% | 行业排名> |
| 2020-12-31 | 45.44% | 11.97% | 11.97% | 93/157 | -148.64% | 首药控股 | 99.93% | 行业排名> |
| 2019-12-31 | 40.58% | 72.54% | 72.54% | 98/157 | -1242.15% | 艾力斯 | 99.41% | 行业排名> |
| 2018-12-31 | 23.52% | 2% | 2% | 123/157 | -211.97% | 艾力斯 | 98.7% | 行业排名> |